Challenges in Classifying Adverse Events in Cancer Clinical Trials Steven Joffe, MD, MPH Dave Harrington, PhD David Studdert, JD, PhD Saul Weingart, MD, PhD Damiana Maloof,…
ART-RIM Workshop National Cancer institute Ethan Basch, MD, MSc Memorial Sloan-Kettering Cancer Center Patient-reported Outcomes (PROs) January 22, 2010 âA PRO is any report…
caBIG Population Sciences SIG Ethan Basch, MD, MSc Memorial Sloan-Kettering Cancer Center PRO-CTCAE A system for patient self-reporting of adverse symptoms in oncology trials…
NCI-sponsored treatment trials: CTCAE v4 790 individual items Standard Approach to AE Monitoring vs. patients CATEGORY EXAMPLE DATA SOURCE Laboratory Neutropenia Laboratory…
JEOPARDY! I Canât Believe Itâs Not JEOPARDY! 100 What is the purpose of clinical trials? To ask specific scientific questions to find better ways to prevent, detect, or…
NCI-sponsored treatment trials: CTCAE v4 790 individual items Standard Approach to AE Monitoring vs. patients CATEGORY EXAMPLE DATA SOURCE Laboratory Neutropenia Laboratory…
ART-RIM Workshop National Cancer institute Ethan Basch, MD, MSc Memorial Sloan-Kettering Cancer Center Patient-reported Outcomes (PROs) January 22, 2010 âA PRO is any report…
Myths and Facts About Cancer Clinical Trials Copyright ENACCT, 2007 Itâs a treatment of âlast resort!â They treat you like a âguinea pigâ No one benefits but the researchers!…
Slide 1 ADENOVIRUS AS A VECTOR IN GENE THERAPY AND VACCINES http://www.virology.net/Big_Virology/EM/Adeno-FD.jpg STRUCTURE Size: 70-90nm Non-enveloped icosahedral virus Capsid…